Purpose: To determine the incidence of diabetic retinopathy (DR) and other ocular findings in previously diagnosed diabetes using telehealth retinal screening with nonmydriatic fundus photography (nFP) in primary care physicians' offices.
Methods: A retrospective study based on electronic chart review was performed. All diabetic patients who participated in the Wills Eye Hospital (WEH) telehealth retinal screening program from July 1, 2012 to February 20, 2017 were included. In addition to evaluation of DR, other eye pathologies of the retina were detected using nFP.
Results: Overall, 9,946 diabetics participated in the WEH telehealth screening system. After exclusion of missing or unreadable images, 15,180 eyes of 7,624 (76.7%) patients were eligible for final analysis. A total of 1,269 (16.6%) patients were noted to have DR changes in at least one eye. Of those, 475 (37.4%) had mild nonproliferative DR (NPDR) in the more severely affected eye, 712 (56.1%) had moderate NPDR, 33 (2.6%) had severe NPDR, 19 (1.5%) had proliferative DR, and 30 (2.4%) have received pan-retinal photocoagulation previously. In addition, there was evidence of diabetic macular edema detectable on nFP in 34 eyes of 29 patients. Other ocular findings included hypertensive retinopathy (709, 9.3%), increased or asymmetric cup-to-disc ratio (562, 7.4%), age-related cataract (379, 5.0%), cotton-wool spots (221, 2.9%), choroidal nevus (74, 1.0%), age-related macular degeneration (AMD) (66, 0.9%), and epiretinal membrane (48, 0.6%). Patients with hypertensive retinopathy, glaucomatous findings, cataract, or AMD were significantly older (
p < 0.001) than those without these ocular pathologies.
Conclusion: The WEH Telehealth Screening Program identified DR in approximately one out of six patients and other ocular pathologies in over 25% of the diabetic population that received screenings in Philadelphia area primary care offices. Given the importance of early detection and routine eye care to prevent vision loss for DR patients, these findings have a significant impact.
Get full access to this article
View all access options for this article.
References
1.
Centers for Disease Control and Prevention. National Diabetes Fact Sheet: National Estimates and General Information on Diabetes and Prediabetes in the United States. Available at https://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf (last accessed September22, 2017).
2.
FederRS, OlsenTW, PrumBE Jr., et al.Comprehensive Adult Medical Eye Evaluation Preferred Practice Pattern(®) Guidelines. Ophthalmology, 2016; 123:209–236.
KirkizlarE, SerbanN, SissonJA, et al.Evaluation of telemedicine for screening of diabetic retinopathy in the Veterans Health Administration. Ophthalmology, 2013; 120:2604–2610.
5.
GrossJG, GlassmanAR, JampolLM, et al.Panretinal photocoagulation vs intravitreous ranibizumab for proliferative diabetic retinopathy: A randomized clinical trial. JAMA, 2015; 314:2137–2146.
6.
National Committee for Quality Assurance. The state of healthcare quality report. 2014. Available at http://ncqa.org (last accessed September25, 2017).
7.
Zimmer-GallerIE, KimuraAE, GuptaS. Diabetic retinopathy screening and the use of telemedicine. Curr Opin Ophthalmol, 2015; 26:167–172.
8.
LiY, KarnowskiTP, TobinKW, et al.A health insurance portability and accountability act-compliant ocular telehealth network for the remote diagnosis and management of diabetic retinopathy. Telemed J E Health, 2011; 17:627–634.
9.
ToyBC, AguinaldoT, EliasonJ, EgbertJ. Non-mydriatic fundus camera screening for referral-warranted diabetic retinopathy in a Northern California safety-net setting. Ophthalmic Surg Lasers Imaging Retina, 2016; 47:636–642.
10.
RathiS, TsuiE, MehtaN, et al.The current state of teleophthalmology in the United States. Ophthalmology, 2017; 124:1729–1734.
11.
HardingS, GreenwoodR, AldingtonS, et al.Grading and disease management in national screening for diabetic retinopathy in England and Wales. Diabet Med, 2003; 20:965–971.
12.
CuadrosJ, BresnickG. EyePACS: An adaptable telemedicine system for diabetic retinopathy screening. J Diabetes Sci Technol, 2009; 3:509–516.
13.
BursellSE, CavalleranoJD, CavalleranoAA, et al.Stereo nonmydriatic digital-video color retinal imaging compared with Early Treatment Diabetic Retinopathy Study seven standard field 35-mm stereo color photos for determining level of diabetic retinopathy. Ophthalmology, 2001; 108:572–585.
14.
CavalleranoAA, CavalleranoJD, KatalinicP, et al.A telemedicine program for diabetic retinopathy in a Veterans Affairs Medical Center—the Joslin Vision Network Eye Health Care Model. Am J Ophthalmol, 2005; 139:597–604.
15.
GuillonM, DumbletonK, TheodoratosP, et al.The effects of age, refractive status, and luminance on pupil size. Optom Vis Sci, 2016; 93:1093–1100.
16.
ScanlonPH, FoyC, MalhotraR, AldingtonSJ. The influence of age, duration of diabetes, cataract, and pupil size on image quality in digital photographic retinal screening. Diabetes Care, 2005; 28:2448–2453.
17.
NguyenHV, TanGS, TappRJ, et al.Cost-effectiveness of a National Telemedicine Diabetic Retinopathy Screening Program in Singapore. Ophthalmology, 2016; 123:2571–2580.
18.
JaniPD, ForbesL, McDanielP, et al.Geographic information systems mapping of diabetic retinopathy in an ocular telemedicine network. JAMA Ophthalmol, 2017; 135:715–721.
19.
OwsleyC, McGwinGJr., LeeDJ, et al.Diabetes eye screening in urban settings serving minority populations: Detection of diabetic retinopathy and other ocular findings using telemedicine. JAMA Ophthalmol, 2015; 133:174–181.
20.
MansbergerSL, GleitsmannK, GardinerS, et al.Comparing the effectiveness of telemedicine and traditional surveillance in providing diabetic retinopathy screening examinations: A randomized controlled trial. Telemed J E Health, 2013; 19:942–948.
21.
JaniPD, ForbesL, ChoudhuryA, et al.Evaluation of diabetic retinal screening and factors for ophthalmology referral in a telemedicine network. JAMA Ophthalmol, 2017; 135:706–714.
22.
ChinEK, VenturaBV, SeeKY, et al.Nonmydriatic fundus photography for teleophthalmology diabetic retinopathy screening in rural and urban clinics. Telemed J E Health, 2014; 20:102–108.
23.
BresnickGH, MukamelDB, DickinsonJC, ColeDR. A screening approach to the surveillance of patients with diabetes for the presence of vision-threatening retinopathy. Ophthalmology, 2000; 107:19–24.
24.
SilvaPS, HortonMB, ClaryD, et al.Identification of diabetic retinopathy and ungradable image rate with ultrawide field imaging in a National Teleophthalmology Program. Ophthalmology, 2016; 123:1360–1367.
25.
ShahidK, KolomeyerAM, NayakNV, et al.Ocular telehealth screenings in an urban community. Telemed J E Health, 2012; 18:95–100.
26.
AsbellPA, DualanI, MindelJ, et al.Age-related cataract. Lancet, 2005; 365:599–609.
27.
HagemanGS, LuthertPJ, Victor ChongNH, et al.An integrated hypothesis that considers drusen as biomarkers of immune-mediated processes at the RPE-Bruch's membrane interface in aging and age-related macular degeneration. Prog Retin Eye Res, 2001; 20:705–732.
KleinBE, KleinR, LeeKE, HoyerCJ. Does the intraocular pressure effect on optic disc cupping differ by age?. Trans Am Ophthalmol Soc, 2006; 104:143–148.
30.
ParkDW, MansbergerSL. Eye disease in patients with diabetes screened with telemedicine. Telemed J E Health, 2017; 23:113–118.
31.
MansbergerSL, ShepplerC, BarkerG, et al.Long-term comparative effectiveness of telemedicine in providing diabetic retinopathy screening examinations: A randomized clinical trial. JAMA Ophthalmol, 2015; 133:518–525.
32.
SharafeldinN, KawaguchiA, SundaramA, et al.Review of economic evaluations of teleophthalmology as a screening strategy for chronic eye disease in adults. Br J Ophthalmol, 2018; 102:1485–1491.
